299 related articles for article (PubMed ID: 32589738)
1. A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia.
El-Maouche D; Merke DP; Vogiatzi MG; Chang AY; Turcu AF; Joyal EG; Lin VH; Weintraub L; Plaunt MR; Mohideen P; Auchus RJ
J Clin Endocrinol Metab; 2020 Aug; 105(8):2771-8. PubMed ID: 32589738
[TBL] [Abstract][Full Text] [Related]
2. Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies.
Sarafoglou K; Barnes CN; Huang M; Imel EA; Madu IJ; Merke DP; Moriarty D; Nakhle S; Newfield RS; Vogiatzi MG; Auchus RJ
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4666-e4679. PubMed ID: 34146101
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM; Stepien KM; Krishan A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901
[TBL] [Abstract][Full Text] [Related]
4. Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.
Auchus RJ; Sarafoglou K; Fechner PY; Vogiatzi MG; Imel EA; Davis SM; Giri N; Sturgeon J; Roberts E; Chan JL; Farber RH
J Clin Endocrinol Metab; 2022 Feb; 107(3):801-812. PubMed ID: 34653252
[TBL] [Abstract][Full Text] [Related]
5. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.
Nella AA; Mallappa A; Perritt AF; Gounden V; Kumar P; Sinaii N; Daley LA; Ling A; Liu CY; Soldin SJ; Merke DP
J Clin Endocrinol Metab; 2016 Dec; 101(12):4690-4698. PubMed ID: 27680873
[TBL] [Abstract][Full Text] [Related]
6. Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
Auer MK; Krumbholz A; Bidlingmaier M; Thieme D; Reisch N
Neuroendocrinology; 2020; 110(11-12):938-949. PubMed ID: 31711056
[TBL] [Abstract][Full Text] [Related]
7. Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia.
Dubinski I; Bechtold Dalla-Pozza S; Bidlingmaier M; Reisch N; Schmidt H
J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1543-1548. PubMed ID: 34523293
[TBL] [Abstract][Full Text] [Related]
8. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].
Ambroziak U; Bednarczuk T; Ginalska-Malinowska M; Małunowicz EM; Grzechocińska B; Kamiński P; Bablok L; Przedlacki J; Bar-Andziak E
Endokrynol Pol; 2010; 61 Suppl 1():7-21. PubMed ID: 22127631
[TBL] [Abstract][Full Text] [Related]
9. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
[TBL] [Abstract][Full Text] [Related]
10. Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers.
Debono M; Mallappa A; Gounden V; Nella AA; Harrison RF; Crutchfield CA; Backlund PS; Soldin SJ; Ross RJ; Merke DP
Eur J Endocrinol; 2015 Dec; 173(6):727-37. PubMed ID: 26340969
[TBL] [Abstract][Full Text] [Related]
11. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
Juniarto AZ; Goossens K; Setyawati BA; Drop SL; de Jong FH; Faradz SM
Singapore Med J; 2011 Nov; 52(11):810-3. PubMed ID: 22173250
[TBL] [Abstract][Full Text] [Related]
12. A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma.
Smith DC; Kroiss M; Kebebew E; Habra MA; Chugh R; Schneider BJ; Fassnacht M; Jafarinasabian P; Ijzerman MM; Lin VH; Mohideen P; Naing A
Invest New Drugs; 2020 Oct; 38(5):1421-1429. PubMed ID: 31984451
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia.
Melin J; Parra-Guillen ZP; Michelet R; Truong T; Huisinga W; Hartung N; Hindmarsh P; Kloft C
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32052005
[TBL] [Abstract][Full Text] [Related]
14. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.
Mallappa A; Sinaii N; Kumar P; Whitaker MJ; Daley LA; Digweed D; Eckland DJ; Van Ryzin C; Nieman LK; Arlt W; Ross RJ; Merke DP
J Clin Endocrinol Metab; 2015 Mar; 100(3):1137-45. PubMed ID: 25494662
[TBL] [Abstract][Full Text] [Related]
15. A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules.
Neumann U; Braune K; Whitaker MJ; Wiegand S; Krude H; Porter J; Digweed D; Voet B; Ross RJM; Blankenstein O
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1433-e1440. PubMed ID: 32888021
[TBL] [Abstract][Full Text] [Related]
16. 17-Hydroxyprogesterone in children, adolescents and adults.
Honour JW
Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
[TBL] [Abstract][Full Text] [Related]
17. Scalp hair 17-hydroxyprogesterone and androstenedione as a long-term therapy monitoring tool in congenital adrenal hyperplasia.
Noppe G; de Rijke YB; Koper JW; van Rossum EF; van den Akker EL
Clin Endocrinol (Oxf); 2016 Oct; 85(4):522-7. PubMed ID: 27061431
[TBL] [Abstract][Full Text] [Related]
18. Congenital Adrenal Hyperplasia in Children: A Pilot Study of Steroid Hormones Expressed as Sex- and Age-Related Standard Deviation Scores.
Clausen CS; Ljubicic ML; Main KM; Andersson AM; Petersen JH; Frederiksen H; Duno M; Johannsen TH; Juul A
Horm Res Paediatr; 2020; 93(4):226-238. PubMed ID: 33017824
[TBL] [Abstract][Full Text] [Related]
19. Invited Commentary: A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia.
Speiser PW
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32777044
[No Abstract] [Full Text] [Related]
20. A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia.
Verma S; Vanryzin C; Sinaii N; Kim MS; Nieman LK; Ravindran S; Calis KA; Arlt W; Ross RJ; Merke DP
Clin Endocrinol (Oxf); 2010 Apr; 72(4):441-7. PubMed ID: 19486026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]